CLINICAL EXPERIMENT WITH PROPIONYLMARIDOMYCIN
スポンサーリンク
概要
- 論文の詳細を見る
Purpose of this paper is to describe clinical evaluation of propionylmaridomycin prescribed to 33 patients with respiratory infectious diseases.<BR>Patients treated were 9 of tonsillitis, 21 of bronchitis, each one of pneumonia and abscess of the lung.<BR>Patients were consisted of 17 males and 16 females and age of patients ranged from 19 to 76 year-old.<BR>Clinical efficacy of propionylmaridomycin in pneumonia, abscess of the lung and tonsillitis was excellent and it was 41% in bronchitis.<BR>Dosage of propionylmaridomycin in tonsillitis, bronchitis and pneumonia was 1, 200 mg t. i. d., and duration was varied from case to case. They were from 3 to 27 days.<BR>Abscess of the lung was treated with propionylmaridomycin 1, 600 mg four times daily for 47 days.<BR>No serious side effects were noted except stomatitis and increased gurgling in 2 cases of bronchitis.
- 公益社団法人 日本化学療法学会の論文
公益社団法人 日本化学療法学会 | 論文
- DISPOSITION OF 7432-8 IN RATS (I)
- CLINICAL STUDIES ON T-1220 IN SURGICAL CASES
- CLINICAL STUDIES OF PIVALOYLOXYMETHYL D-α-AMINOBENZYL-PENICILLINATE HYDROCHLORIDE IN SURGICAL INFECTIONS
- STUDIES ON AC-1370
- Primary treatment with a combination of cyclophosphamide, vincristine, and dacarbazine for recurrent malignant pheochromocytoma: A case report.